Cargando…

Tissue-resident memory T cells in chronic liver diseases: Phenotype, development and function

Tissue-resident memory (T(RM)) T cells are a unique subset of memory T cells that are critical for the first line of defense against pathogens or antigens in peripheral non-lymphoid tissues such as liver, gut, and skin. Generally, T(RM) cells are well adapted to the local environment in a tissue-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yikang, You, Zhengrui, Tang, Ruqi, Ma, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511135/
https://www.ncbi.nlm.nih.gov/pubmed/36172356
http://dx.doi.org/10.3389/fimmu.2022.967055
Descripción
Sumario:Tissue-resident memory (T(RM)) T cells are a unique subset of memory T cells that are critical for the first line of defense against pathogens or antigens in peripheral non-lymphoid tissues such as liver, gut, and skin. Generally, T(RM) cells are well adapted to the local environment in a tissue-specific manner and typically do not circulate but persist in tissues, distinguishing them from other memory T cell lineages. There is strong evidence that liver T(RM) cells provide a robust adaptive immune response to potential threats. Indeed, the potent effector function of hepatic T(RM) cells makes it essential for chronic liver diseases, including viral and parasite infection, autoimmune liver diseases (AILD), nonalcoholic fatty liver disease (NAFLD), hepatocellular carcinoma (HCC) and liver transplantation. Manipulation of hepatic T(RM) cells might provide novel promising strategies for precision immunotherapy of chronic liver diseases. Here, we provide insights into the phenotype of hepatic T(RM) cells through surface markers, transcriptional profiles and effector functions, discuss the development of hepatic T(RM) cells in terms of cellular origin and factors affecting their development, analyze the role of hepatic T(RM) cells in chronic liver diseases, as well as share our perspectives on the current status of hepatic T(RM) cell research.